Italian observational study on T-DM1 in HER2 positive advanced breast cancer patients: real world effectiveness and safety

被引：0
|
作者：
Fabi, A. [1 ]
Alesini, D. [1 ]
De laurentiis, M. [2 ]
Valle, E. [3 ]
Santini, D. [4 ]
Cannita, K. [5 ]
Carbognin, L. [6 ]
Ciccarese, M. [7 ]
Arpino, G. [8 ]
Leonardi, V. [9 ]
Montemurro, F. [10 ]
La Verde, N. [11 ]
Generali, D. G. [12 ]
Scandurra, G. [13 ]
Russillo, M. [14 ]
Paris, I. [15 ]
D'Ottavio, A. M. [16 ]
Filippelli, G. [17 ]
Stani, S. [18 ]
Giannarelli, D. [1 ]
Cognetti, F. [1 ]
机构：
[1] Ist Nazl Tumori Regina Elena, Rome, Italy
[2] Fdn Pascale, Ist Nazl Tumori, Naples, Italy
[3] Osped A Businco, Cagliari, Italy
[4] Campus Bio Med, Rome, Italy
[5] Presidio Osped S Salvatore, Laquila, Italy
[6] Azienda Univ Integrata Verona, Verona, Italy
[7] Osped Vito Fazzi, Lecce, Italy
[8] Univ Federico II, Naples, Italy
[9] ARNAS Civ, Palermo, Italy
[10] Fdn Piemonte Oncol, Candiolo, Italy
[11] Osped San Raffaele, Milan, Italy
[12] Ist Osped, Cremona, Italy
[13] Osped Oncol, Catania, Italy
[14] Osped Oncol, Lucca, Italy
[15] Univ Cattolica Sacro Cuore A Gemelli, Rome, Italy
[16] Osped S Giovanni Addolorata, Rome, Italy
[17] Osped S Francesco Paola, Paola, Italy
[18] Osped Santo Spirito, Rome, Italy
来源：
ANNALS OF ONCOLOGY | 2016年 / 27卷
关键词：
D O I：
10.1093/annonc/mdw337.7
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
F07
引用
收藏
页数：1
相关论文
共 50 条
  • [21] mTOR Inhibition and T-DM1 in HER2-Positive Breast Cancer
    Casadevall, David
    Hernandez-Prat, Anna
    Garcia-Alonso, Sara
    Arpi-Llucia, Oriol
    Menendez, Silvia
    Qin, Mengjuan
    Guardia, Cristina
    Morancho, Beatriz
    Sanchez-Martin, Francisco Javier
    Zazo, Sandra
    Gavilan, Elena
    Sabbaghi, Mohammad A.
    Eroles, Pilar
    Cejalvo, Juan Miguel
    Lluch, Ana
    Rojo, Federico
    Pandiella, Atanasio
    Rovia, Ana
    Anabell, Joan
    MOLECULAR CANCER RESEARCH, 2022, 20 (07) : 1108 - 1121
  • [22] Trastuzumab emtansine (T-DM1) for HER2-positive breast cancer
    Boyraz, Baris
    Sendur, Mehmet A. N.
    Aksoy, Sercan
    Babacan, Taner
    Roach, Emir C.
    Kizilarslanoglu, Muhammet C.
    Petekkaya, Ibrahim
    Altundag, Kadri
    CURRENT MEDICAL RESEARCH AND OPINION, 2013, 29 (04) : 405 - 414
  • [23] T-DM1 for residual, invasive, HER2-positive breast cancer
    Burki, Talha Khan
    LANCET ONCOLOGY, 2019, 20 (01): : E13 - E13
  • [24] Efficacy and safety of trastuzumab emtansine (T-DM1) in patients with HER2-positive breast cancer with brain metastases
    Jacot, William
    Pons, Elvire
    Frenel, Jean-Sebastien
    Guiu, Severine
    Levy, Christelle
    Heudel, Pierre Etienne
    Bachelot, Thomas
    D'Hondt, Veronique
    Darlix, Amelie
    Firmin, Nelly
    Romieu, Gilles
    Thezenas, Simon
    Dalenc, Florence
    BREAST CANCER RESEARCH AND TREATMENT, 2016, 157 (02) : 307 - 318
  • [25] Efficacy and safety of trastuzumab emtansine (T-DM1) in patients with HER2-positive breast cancer with brain metastases
    William Jacot
    Elvire Pons
    Jean-Sébastien Frenel
    Séverine Guiu
    Christelle Levy
    Pierre Etienne Heudel
    Thomas Bachelot
    Véronique D’Hondt
    Amélie Darlix
    Nelly Firmin
    Gilles Romieu
    Simon Thezenas
    Florence Dalenc
    Breast Cancer Research and Treatment, 2016, 157 : 307 - 318
  • [26] T-DM1 Efficacy in Patients With HER2-positive Metastatic Breast Cancer Progressing After a Taxane Plus Pertuzumab and Trastuzumab: An Italian Multicenter Observational Study
    Conte, Benedetta
    Fabi, Alessandra
    Poggio, Francesca
    Blondeaux, Eva
    Dellepiane, Chiara
    D'Alonzo, Alessia
    Buono, Giuseppe
    Arpino, Grazia
    Magri, Valentina
    Naso, Giuseppe
    Presti, Daniele
    Mura, Silvia
    Fontana, Andrea
    Cognetti, Francesco
    Molinelli, Chiara
    Pastorino, Simona
    Bighin, Claudia
    Miglietta, Loredana
    Boccardo, Francesco
    Lambertini, Matteo
    Del Mastro, Lucia
    CLINICAL BREAST CANCER, 2020, 20 (02) : E181 - E187
  • [27] Safety and efficacy of T-DM1 in 128 patients with advanced HER2+breast cancer: The Royal Marsden experience
    Battisti, N. M. L.
    Lee, K. A.
    Shepherd, S.
    Rogerson, F.
    Mohammed, K.
    Allen, M.
    Ring, A.
    ANNALS OF ONCOLOGY, 2019, 30 : 128 - +
  • [28] Real-world data on T-DM1 efficacy – results of a single-center retrospective study of HER2-positive breast cancer patients
    Max Hardy-Werbin
    Vanesa Quiroga
    Beatriz Cirauqui
    Margarita Romeo
    Eudald Felip
    Iris Teruel
    Juan Jose Garcia
    Carlos Erasun
    Sofia España
    Marc Cucurull
    Elisabeth Montprade
    Juan Carlos Pardo
    Dania Carballo
    Jose Maria Velarde
    Mireia Margeli
    Scientific Reports, 9
  • [29] Real-world data on T-DM1 efficacy - results of a single-center retrospective study of HER2-positive breast cancer patients
    Hardy-Werbin, Max
    Quiroga, Vanesa
    Cirauqui, Beatriz
    Romeo, Margarita
    Felip, Eudald
    Teruel, Iris
    Jose Garcia, Juan
    Erasun, Carlos
    Espana, Sofia
    Cucurull, Marc
    Montprade, Elisabeth
    Carlos Pardo, Juan
    Carballo, Dania
    Maria Velarde, Jose
    Margeli, Mireia
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [30] Complete Cerebrospinal Fluid Response to T-DM1 in HER2 Positive Metastatic Breast Cancer: A Case Report
    Zacchi, Francesca
    Giontella, Elena
    Nottegar, Alessia
    Fiorio, Elena
    LIFE-BASEL, 2023, 13 (03):
12345